Clinical Trial Update: Theophylline Nasal Spray for PD-Related Hyposmia and Anosmia [Phase 1]

View source ↗

Summary

Phase 1 trial of theophylline nasal spray for Parkinson's disease-related hyposmia and anosmia has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• Theophylline nasal spray (theophylline)

Snippet

Sponsor: University of Nebraska | Conditions: Hyposmia, Anosmia | Phase 1 | Status: WITHDRAWN